Natalie S. Nunnally
Centers for Disease Control and Prevention(US)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Fungal Infections and Studies, Infectious Diseases and Mycology, Antimicrobial Resistance in Staphylococcus, Synthesis and Biological Evaluation
Most-Cited Works
- → The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic(2021)134 cited
- → In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations(2019)62 cited
- → Detection of TR 34 /L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017(2018)52 cited
- → In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents(2021)45 cited
- → Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States(2021)41 cited
- → Antifungal activity of nikkomycin Z against Candida auris(2021)28 cited
- → In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans(2023)17 cited
- → Fatal Fungicide-Associated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA(2022)15 cited
- → Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease—Georgia, United States, 2017–2019(2022)14 cited
- → Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates(2024)14 cited